Selected research
Industry Research
Felypressin Industry Research Report 2026
Market perspective
The global Felypressin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Felypressin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Felypressin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Felypressin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Felypressin include Peptide, WellMan, TargetMol, TaiTan, Maclin, Nanjing Peptide, Nanjing Leon, JunYu and AikonChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Felypressin market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Felypressin Market by Company
Peptide
WellMan
TargetMol
TaiTan
Maclin
Nanjing Peptide
Nanjing Leon
JunYu
AikonChem
JuSheng
Sai Mannuo
Gotopbio
Mreda
Vulcanchem
Toronto Research Chemicals
Medical Isotopes
Glentham Life Sciences
Crysdot
ChemScene
CacheSyn
BOC Sciences
BIOTREND Chemicals AG
Felypressin Segment by Type
90% Purity
95% Purity
98% Purity
99% Purity
Felypressin Segment by Application
Medical
Health Products
Felypressin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felypressin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Felypressin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felypressin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Felypressin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Felypressin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Felypressin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 90% Purity
- 95% Purity
- 98% Purity
- 99% Purity
Applications
- Medical
- Health Products
Companies covered
- Peptide
- WellMan
- TargetMol
- TaiTan
- Maclin
- Nanjing Peptide
- Nanjing Leon
- JunYu
- AikonChem
- JuSheng
- Sai Mannuo
- Gotopbio
- Mreda
- Vulcanchem
- Toronto Research Chemicals
- Medical Isotopes
- Glentham Life Sciences
- Crysdot
- ChemScene
- CacheSyn
- BOC Sciences
- BIOTREND Chemicals AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Felypressin Market Size (2021-2032)
- 2.2.2 Global Felypressin Sales (2021-2032)
- 2.2.3 Global Felypressin Market Average Price (2021-2032)
- 2.3 Felypressin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 90% Purity
- 2.3.3 95% Purity
- 2.3.4 98% Purity
- 2.3.5 99% Purity
- 2.4 Felypressin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical
- 2.4.3 Health Products
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Felypressin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Felypressin Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Felypressin Revenue of Manufacturers (2021-2026)
- 3.4 Global Felypressin Average Price by Manufacturers (2021-2026)
- 3.5 Global Felypressin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Felypressin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Felypressin, Product Type & Application
- 3.8 Global Manufacturers of Felypressin, Established Date
- 3.9 Global Felypressin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Peptide
- 4.1.1 Peptide Company Information
- 4.1.2 Peptide Business Overview
- 4.1.3 Peptide Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Peptide Felypressin Product Portfolio
- 4.1.5 Peptide Recent Developments
- 4.2 WellMan
- 4.2.1 WellMan Company Information
- 4.2.2 WellMan Business Overview
- 4.2.3 WellMan Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 WellMan Felypressin Product Portfolio
- 4.2.5 WellMan Recent Developments
- 4.3 TargetMol
- 4.3.1 TargetMol Company Information
- 4.3.2 TargetMol Business Overview
- 4.3.3 TargetMol Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 TargetMol Felypressin Product Portfolio
- 4.3.5 TargetMol Recent Developments
- 4.4 TaiTan
- 4.4.1 TaiTan Company Information
- 4.4.2 TaiTan Business Overview
- 4.4.3 TaiTan Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 TaiTan Felypressin Product Portfolio
- 4.4.5 TaiTan Recent Developments
- 4.5 Maclin
- 4.5.1 Maclin Company Information
- 4.5.2 Maclin Business Overview
- 4.5.3 Maclin Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Maclin Felypressin Product Portfolio
- 4.5.5 Maclin Recent Developments
- 4.6 Nanjing Peptide
- 4.6.1 Nanjing Peptide Company Information
- 4.6.2 Nanjing Peptide Business Overview
- 4.6.3 Nanjing Peptide Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nanjing Peptide Felypressin Product Portfolio
- 4.6.5 Nanjing Peptide Recent Developments
- 4.7 Nanjing Leon
- 4.7.1 Nanjing Leon Company Information
- 4.7.2 Nanjing Leon Business Overview
- 4.7.3 Nanjing Leon Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nanjing Leon Felypressin Product Portfolio
- 4.7.5 Nanjing Leon Recent Developments
- 4.8 JunYu
- 4.8.1 JunYu Company Information
- 4.8.2 JunYu Business Overview
- 4.8.3 JunYu Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 JunYu Felypressin Product Portfolio
- 4.8.5 JunYu Recent Developments
- 4.9 AikonChem
- 4.9.1 AikonChem Company Information
- 4.9.2 AikonChem Business Overview
- 4.9.3 AikonChem Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AikonChem Felypressin Product Portfolio
- 4.9.5 AikonChem Recent Developments
- 4.10 JuSheng
- 4.10.1 JuSheng Company Information
- 4.10.2 JuSheng Business Overview
- 4.10.3 JuSheng Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 JuSheng Felypressin Product Portfolio
- 4.10.5 JuSheng Recent Developments
- 4.11 Sai Mannuo
- 4.11.1 Sai Mannuo Company Information
- 4.11.2 Sai Mannuo Business Overview
- 4.11.3 Sai Mannuo Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sai Mannuo Felypressin Product Portfolio
- 4.11.5 Sai Mannuo Recent Developments
- 4.12 Gotopbio
- 4.12.1 Gotopbio Company Information
- 4.12.2 Gotopbio Business Overview
- 4.12.3 Gotopbio Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Gotopbio Felypressin Product Portfolio
- 4.12.5 Gotopbio Recent Developments
- 4.13 Mreda
- 4.13.1 Mreda Company Information
- 4.13.2 Mreda Business Overview
- 4.13.3 Mreda Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Mreda Felypressin Product Portfolio
- 4.13.5 Mreda Recent Developments
- 4.14 Vulcanchem
- 4.14.1 Vulcanchem Company Information
- 4.14.2 Vulcanchem Business Overview
- 4.14.3 Vulcanchem Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Vulcanchem Felypressin Product Portfolio
- 4.14.5 Vulcanchem Recent Developments
- 4.15 Toronto Research Chemicals
- 4.15.1 Toronto Research Chemicals Company Information
- 4.15.2 Toronto Research Chemicals Business Overview
- 4.15.3 Toronto Research Chemicals Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Toronto Research Chemicals Felypressin Product Portfolio
- 4.15.5 Toronto Research Chemicals Recent Developments
- 4.16 Medical Isotopes
- 4.16.1 Medical Isotopes Company Information
- 4.16.2 Medical Isotopes Business Overview
- 4.16.3 Medical Isotopes Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Medical Isotopes Felypressin Product Portfolio
- 4.16.5 Medical Isotopes Recent Developments
- 4.17 Glentham Life Sciences
- 4.17.1 Glentham Life Sciences Company Information
- 4.17.2 Glentham Life Sciences Business Overview
- 4.17.3 Glentham Life Sciences Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Glentham Life Sciences Felypressin Product Portfolio
- 4.17.5 Glentham Life Sciences Recent Developments
- 4.18 Crysdot
- 4.18.1 Crysdot Company Information
- 4.18.2 Crysdot Business Overview
- 4.18.3 Crysdot Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Crysdot Felypressin Product Portfolio
- 4.18.5 Crysdot Recent Developments
- 4.19 ChemScene
- 4.19.1 ChemScene Company Information
- 4.19.2 ChemScene Business Overview
- 4.19.3 ChemScene Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 ChemScene Felypressin Product Portfolio
- 4.19.5 ChemScene Recent Developments
- 4.20 CacheSyn
- 4.20.1 CacheSyn Company Information
- 4.20.2 CacheSyn Business Overview
- 4.20.3 CacheSyn Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 CacheSyn Felypressin Product Portfolio
- 4.20.5 CacheSyn Recent Developments
- 4.21 BOC Sciences
- 4.21.1 BOC Sciences Company Information
- 4.21.2 BOC Sciences Business Overview
- 4.21.3 BOC Sciences Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 BOC Sciences Felypressin Product Portfolio
- 4.21.5 BOC Sciences Recent Developments
- 4.22 BIOTREND Chemicals AG
- 4.22.1 BIOTREND Chemicals AG Company Information
- 4.22.2 BIOTREND Chemicals AG Business Overview
- 4.22.3 BIOTREND Chemicals AG Felypressin Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 BIOTREND Chemicals AG Felypressin Product Portfolio
- 4.22.5 BIOTREND Chemicals AG Recent Developments
5 Global Felypressin Market Scenario by Region
- 5.1 Global Felypressin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Felypressin Sales by Region: 2021-2032
- 5.2.1 Global Felypressin Sales by Region: 2021-2026
- 5.2.2 Global Felypressin Sales by Region: 2027-2032
- 5.3 Global Felypressin Revenue by Region: 2021-2032
- 5.3.1 Global Felypressin Revenue by Region: 2021-2026
- 5.3.2 Global Felypressin Revenue by Region: 2027-2032
- 5.4 North America Felypressin Market Facts & Figures by Country
- 5.4.1 North America Felypressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Felypressin Sales by Country (2021-2032)
- 5.4.3 North America Felypressin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Felypressin Market Facts & Figures by Country
- 5.5.1 Europe Felypressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Felypressin Sales by Country (2021-2032)
- 5.5.3 Europe Felypressin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Felypressin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Felypressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Felypressin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Felypressin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Felypressin Market Facts & Figures by Country
- 5.7.1 South America Felypressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Felypressin Sales by Country (2021-2032)
- 5.7.3 South America Felypressin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Felypressin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Felypressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Felypressin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Felypressin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Felypressin Sales by Type (2021-2032)
- 6.1.1 Global Felypressin Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Felypressin Sales Market Share by Type (2021-2032)
- 6.2 Global Felypressin Revenue by Type (2021-2032)
- 6.2.1 Global Felypressin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Felypressin Revenue Market Share by Type (2021-2032)
- 6.3 Global Felypressin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Felypressin Sales by Application (2021-2032)
- 7.1.1 Global Felypressin Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Felypressin Sales Market Share by Application (2021-2032)
- 7.2 Global Felypressin Revenue by Application (2021-2032)
- 7.2.1 Global Felypressin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Felypressin Revenue Market Share by Application (2021-2032)
- 7.3 Global Felypressin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Felypressin Value Chain Analysis
- 8.1.1 Felypressin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Felypressin Production Mode & Process
- 8.2 Felypressin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Felypressin Distributors
- 8.2.3 Felypressin Customers
9 Global Felypressin Analyzing Market Dynamics
- 9.1 Felypressin Industry Trends
- 9.2 Felypressin Industry Drivers
- 9.3 Felypressin Industry Opportunities and Challenges
- 9.4 Felypressin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst